Katsumi Tomohiro, Ninomiya Masashi, Nishina Taketo, Mizuno Kei, Tomita Kyoko, Haga Hiroaki, Okumoto Kazuo, Saito Takafumi, Shimosegawa Tooru, Ueno Yoshiyuki
Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Lab Invest. 2016 Nov;96(11):1165-1177. doi: 10.1038/labinvest.2016.95. Epub 2016 Sep 26.
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized pathologically by destruction of intrahepatic bile ducts. PBC is largely classified into three subtypes based on clinical course: (i) gradually progressive, (ii) portal hypertension, and (iii) hepatic failure. Previous studies have indicated that serum levels of the pro-inflammatory cytokine TNF-α, is elevated in PBC patients with fibrosis. Although the severity of cholangitis might also be related to the PBC subtype, its etiology has been unclear. Several studies have shown that microRNAs (miRNAs) demonstrate specific expression patterns in various diseases. In the present study, we evaluated miRNA expression patterns among the PBC subtypes using comprehensive deep sequencing. We also carried out histologic examination by laser capture microdissection and investigated how the identified miRNAs were involved in PBC clinical progression using the miRNA transfection method. On average, ~11 million 32-mer short RNA reads per sample were obtained, and we found that the expression levels of 97 miRNAs differed significantly among the four groups. Heat mapping demonstrated that the miRNA profiles from hepatic failure and portal hypertension type were clustered differently from those of the gradually progressive type and controls. Furthermore, we focused on miR-139-5p, which has an adequate number of total short reads. Quantitative reverse transcription PCR showed that miR-139-5p was significantly downregulated in clinically advanced PBC. Also, examination of liver tissues demonstrated that the expression of lymphocyte-derived miR-139-5p was significantly higher in hepatocytes. In vitro, the level of TNF-α was significantly elevated in supernatant of cells with upregulation of miR-139-5p. Furthermore, c-FOS gene transcription was repressed. Thus, we have demonstrated a novel inflammation-regulatory mechanism involving TNF-α and c-FOS transcription through miR-139-5p in the NF-κB signaling pathway. We conclude that the specific miRNA miR-139-5p might be involved in the pathogenesis of PBC, especially during clinical progression.
原发性胆汁性胆管炎(PBC)是一种慢性胆汁淤积性肝病,其病理特征为肝内胆管破坏。PBC在很大程度上根据临床病程分为三种亚型:(i)逐渐进展型,(ii)门静脉高压型,(iii)肝衰竭型。先前的研究表明,在伴有纤维化的PBC患者中,促炎细胞因子TNF-α的血清水平升高。尽管胆管炎的严重程度可能也与PBC亚型有关,但其病因尚不清楚。多项研究表明,微小RNA(miRNA)在各种疾病中呈现特定的表达模式。在本研究中,我们使用全面深度测序评估了PBC各亚型之间的miRNA表达模式。我们还通过激光捕获显微切割进行了组织学检查,并使用miRNA转染方法研究了所鉴定的miRNA如何参与PBC的临床进展。每个样本平均获得约1100万个32聚体短RNA读数,我们发现97种miRNA的表达水平在四组之间存在显著差异。热图显示,肝衰竭型和门静脉高压型的miRNA谱与逐渐进展型和对照组的聚类方式不同。此外,我们关注了总短读数数量充足的miR-139-5p。定量逆转录PCR显示,miR-139-5p在临床晚期PBC中显著下调。此外,肝脏组织检查表明,淋巴细胞来源的miR-139-5p在肝细胞中的表达显著更高。在体外,miR-139-5p上调的细胞上清液中TNF-α水平显著升高。此外,c-FOS基因转录受到抑制。因此,我们证明了一种新的炎症调节机制,即通过NF-κB信号通路中的miR-139-5p参与TNF-α和c-FOS转录。我们得出结论,特定的miRNA miR-139-5p可能参与PBC的发病机制,尤其是在临床进展过程中。